Atrás
82
Rango del Día
$1.85
$1.94
Rango de 52 Semanas
$1.85
$3.92
Volumen
4,657,086
Promedio 50D / 200D
$2.19
/
$2.65
Cierre Anterior
$1.89
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -11.1 | 0.4 |
| P/B | 3.1 | 2.9 |
| ROE % | -26.3 | 3.8 |
| Net Margin % | -4.5 | 3.9 |
| Rev Growth 5Y % | 6.9 | 10.0 |
| D/E | 0.0 | 0.2 |
Precio Objetivo de Analistas
Hold
$3.00
+62.2%
P/E Futuro
43.2
EPS Futuro
$0.04
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
2.9 B
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$0.28
$0.28 – $0.28
|
4.8 B | 1 |
| FY2029 |
$0.21
$0.21 – $0.21
|
4.3 B | 1 |
| FY2028 |
$0.12
$0.06 – $0.18
|
3.7 B | 2 |
Puntos Clave
Revenue grew 6.93% annually over 5 years — modest growth
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -68.98M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 33.41%
Capital efficient — spends only 0.11% of revenue on capex
Crecimiento
Revenue Growth (5Y)
6.93%
Revenue (1Y)40.34%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-26.33%
ROIC-20.78%
Net Margin-4.45%
Op. Margin-4.44%
Seguridad
Debt / Equity
0.00
Current Ratio1.47
Interest Coverage0.00
Valoración
P/E Ratio
-11.07
P/B Ratio3.07
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 40.34% | Revenue Growth (3Y) | 23.55% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 6.93% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1.92B | Net Income (TTM) | -85.55M |
| ROE | -26.33% | ROA | -15.81% |
| Gross Margin | 18.49% | Operating Margin | -4.44% |
| Net Margin | -4.45% | Free Cash Flow (TTM) | -68.98M |
| ROIC | -20.78% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 1.47 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -11.07 | P/B Ratio | 3.07 |
| P/S Ratio | 0.49 | PEG Ratio | -0.15 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 947.16M | Enterprise Value | 868.86M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.92B | 1.37B | 1.26B | 1.10B | 1.47B |
| Net Income | -85.55M | -43.01M | -213.36M | -339.57M | -587.76M |
| EPS (Diluted) | -0.17 | -0.09 | -0.45 | -0.71 | -1.25 |
| Gross Profit | 355.88M | 364.80M | 255.95M | 103.48M | -79.18M |
| Operating Income | -85.53M | -45.75M | -205.33M | -286.66M | -636.99M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 541.01M | 580.74M | 570.67M | 808.62M | 950.80M |
| Total Liabilities | 232.31M | 239.60M | 284.28M | 451.73M | 411.49M |
| Shareholders' Equity | 308.70M | 341.14M | 286.39M | 356.89M | 535.41M |
| Total Debt | 0.0 | 0.0 | 4.66M | 5.86M | 27.83M |
| Cash & Equivalents | 78.30M | 194.54M | 116.41M | 103.79M | 299.97M |
| Current Assets | 307.86M | 343.12M | 427.97M | 625.00M | 752.55M |
| Current Liabilities | 208.82M | 213.52M | 261.12M | 431.51M | 372.62M |
Puntuaciones de Estrategias
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#35 of 616
Actividad Reciente
Entró
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026